News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Symbollon Pharmaceuticals (SYMBA) Forms Joint Venture with Internet Marketing Consortium to Promote Iogen(TM)


6/21/2010 10:18:14 AM

MEDFIELD, Mass., June 21, 2010 (GLOBE NEWSWIRE) -- Symbollon Pharmaceuticals, Inc. (OTCBB:SYMBA) (www.symbollon.com) has announced today it has signed a non-exclusive joint venture agreement with Internet Marketing Consortium (IMC) to promote Iogen™. The purpose of the joint venture is to utilize the proprietary internet and multi-media marketing strategies and networks to promote Iogen™ through website sales on www.buyiogen.com. IMC is part of Beryl Wolk's family-owned businesses comprising 27 autonomous companies, employing 1,250 employees, with major facilities in four states and 66 offices worldwide. The parties will share 50/50% in the profits of the joint venture. Iogen™ is the first dietary supplement formulated to promote breast health for women suffering from breast pain and breast tenderness, fibrocystic breast disease, benign breast lumps and cysts.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES